Terbinafine dosage and administration: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Terbinafine}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Dosage and Administration== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600e2b3-65df-4fc3-8081-d574537d27e3 | publisher = | date = | accessdate = }}</ref> | *'''Fingernail [[onychomycosis]]''' | ||
One 250 mg tablet once daily for 6 weeks. | |||
*'''Toenail [[onychomycosis]]''' | |||
One 250 mg tablet once daily for 12 weeks. | |||
The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERBINAFINE (TERBINAFINE HYDROCHLORIDE) TABLET [AUROBINDO PHARMA LIMITED] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6600e2b3-65df-4fc3-8081-d574537d27e3 | publisher = | date = | accessdate = }}</ref> | |||
'''Other FDA approved preparations''' | |||
*Cream;Topical: 1% | |||
*Granule;Oral: EQ 125MG BASE/PACKET ; EQ 187.5MG BASE/PACKET | |||
*Tablet;Oral: EQ 250MG BASE | |||
==References== | ==References== | ||
Latest revision as of 22:07, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Dosage and Administration
- Fingernail onychomycosis
One 250 mg tablet once daily for 6 weeks.
- Toenail onychomycosis
One 250 mg tablet once daily for 12 weeks.
The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.[1]
Other FDA approved preparations
- Cream;Topical: 1%
- Granule;Oral: EQ 125MG BASE/PACKET ; EQ 187.5MG BASE/PACKET
- Tablet;Oral: EQ 250MG BASE
References
Adapted from the FDA Package Insert.